United Kingdom-Leeds: Sprionaloctone
Details
Contract Title: | United Kingdom-Leeds: Sprionaloctone |
Published Date: | Feb 28, 2025 |
Notice Type: | Notice (PriorInformationNotice) |
Value Banding: | High Value |
Delivery Point: | United Kingdom |
Description:
NHS England has published this Preliminary Market Engagement Notice for the Licence variation: spironolactone for acne in women. It is anticipated that there will be two separate contracts to deliver this, as outlined below. • Contract A: Prepare an application for a major (type II) MHRA Marketing Authorisation variation for spironolactone. • Contract B: Submit the pre-prepared application to the MHRA. Only current Marketing Authorisation Holders of spironolactone are eligible to bid for contrac...